PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial-MedSci.cn

PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial

Brown, H; Vansteenkiste, J; Nakagawa, K; Dols, MC; John, T; Barker, C; Kohlmann, A; Todd, A; Saggese, M; Chmielecki, J; Markovets, A; Ramalingam, S

JOURNAL OF THORACIC ONCOLOGY, 2018; 13 (10): S408

科室
- - 订阅+
  - 更多科室
工具
服务